Patients Living With Gerd Now Have A New Treatment Option For Improved And Sustained Symptom Relief

Friday, Apr. 15th 2011 6:24 AM

Takeda is pleased to announce that DEXILANT™ (dexlansoprazole) is now available in Canada. DEXILANT is the first and only proton pump inhibitor (PPI) with a novel DUAL DELAYED RELEASE technology, which delivers two separate doses of medication at different times providing improved and sustained symptom relief throughout the day and night.

VN:F [1.9.22_1171]
Rating: 5.0/5 (2 votes cast)
VN:F [1.9.22_1171]
Rating: +1 (from 1 vote)
Patients Living With Gerd Now Have A New Treatment Option For Improved And Sustained Symptom Relief, 5.0 out of 5 based on 2 ratings
Posted on Friday, Apr. 15th 2011 6:24 AM | by Share of Cost | in Share of Cost | No Comments »

Leave a Reply